Viewing Study NCT01733758


Ignite Creation Date: 2025-12-25 @ 12:03 AM
Ignite Modification Date: 2025-12-29 @ 7:53 AM
Study NCT ID: NCT01733758
Status: COMPLETED
Last Update Posted: 2016-09-22
First Post: 2012-11-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-02
Start Date Type: None
Primary Completion Date: 2014-06
Primary Completion Date Type: ACTUAL
Completion Date: 2015-02
Completion Date Type: ACTUAL
First Submit Date: 2012-11-21
First Submit QC Date: None
Study First Post Date: 2012-11-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2015-04-02
Results First Submit QC Date: None
Results First Post Date: 2015-05-18
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-08-12
Last Update Post Date: 2016-09-22
Last Update Post Date Type: ESTIMATED